<DOC>
	<DOCNO>NCT00098969</DOCNO>
	<brief_summary>RATIONALE : Chemoprevention use certain drug keep cancer forming , grow , come back . The use resveratrol may prevent cancer . PURPOSE : This phase I trial study side effect best dose resveratrol prevent cancer healthy participant .</brief_summary>
	<brief_title>UMCC 2003-064 Resveratrol Preventing Cancer Healthy Participants</brief_title>
	<detailed_description>OBJECTIVES : - Determine concentration resveratrol metabolites plasma , urine , feces healthy participant . - Correlate dose systemic concentration drug metabolites participant . - Determine safety drug participant . OUTLINE : This open-label , dose-escalation , multicenter study . Beginning 5 day study drug administration , participant put control diet ( avoid resveratrol-containing food drink ) washout . Participants receive oral resveratrol day 1 . Cohorts 10 participant receive escalate dos resveratrol maximum tolerate dose ( MTD ) determine . The MTD define dose precede 2 10 participant experience dose-limiting toxicity . A total 16 participant treat MTD . Participants follow 2 7 day . PROJECTED ACCRUAL : A total 10-40 participant accrue study within 6 month .</detailed_description>
	<mesh_term>Resveratrol</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Healthy participant PATIENT CHARACTERISTICS : Age 18 80 Performance status WHO 01 Life expectancy Not specify Hematopoietic Absolute neutrophil count &gt; 1,500/mm^3 Platelet count 120,000450,000mm^3 Hemoglobin 10.517.5 g/dL woman OR 11.519.0 g/dL men Hepatic Bilirubin 0.051.2 mg/dL AST ALT &lt; 1.5 time normal Renal Creatinine normal Urinalysis normal Other Not pregnant nursing Negative pregnancy test Fertile participant must use effective contraception Willing abstain ingest large quantity resveratrolcontaining food Willing spend 24 hour hospital No cancer diagnosis currently treatment , clinically detectable , treat within past 5 year except basal cell squamous cell skin cancer No concurrent excessive alcohol intake ( &gt; 21 unit per week men ; 14 unit per week woman ) PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Concurrent hormone replace ment therapy allow Concurrent oral depot contraceptive allow Radiotherapy Not specify Surgery Not specify Other At least 2 week since prior concurrent vitamin supplement type More 6 month since prior concurrent participation experimental study No concurrent chronic medication , include overthecounter medication , herbal/natural preparation , dietary supplement No concurrent prescribe medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>